Table 6.

Summary of data of chronic B-cell leukemia with 2 complete immunoglobulin light chain rearrangements, as identified by reverse transcriptase–polymerase chain reaction analysis and sequencing

IGK/IGKIGK/IGLIGL/IGLTotal
Patients (see Tables 3-5) 12, 14-17 1-36-150, 5-10 46-151, 20-26, 28,  29, 32 n = 26  
2 functional rearrangements 0/6 5/9 5/11 10/26  
Somatic mutations in cases with:     
 1 functional rearrangement 2/6 1/4 2/6 5/16  
 2 functional rearrangements − 3/5 5/5 8/10  
Both functional rearrangements transcribed − 4/4 5/5 9/9  
Double Ig light chain protein expression − 0/5 Not evaluable 0/5 
IGK/IGKIGK/IGLIGL/IGLTotal
Patients (see Tables 3-5) 12, 14-17 1-36-150, 5-10 46-151, 20-26, 28,  29, 32 n = 26  
2 functional rearrangements 0/6 5/9 5/11 10/26  
Somatic mutations in cases with:     
 1 functional rearrangement 2/6 1/4 2/6 5/16  
 2 functional rearrangements − 3/5 5/5 8/10  
Both functional rearrangements transcribed − 4/4 5/5 9/9  
Double Ig light chain protein expression − 0/5 Not evaluable 0/5 

Ig indicates immunoglobulin; CBL, chronic B-cell leukemia.

F6-150

Patient 3 was classified in the IGK/IGL category, because this Igκ+ CBL contained a functional IGLrearrangement.

F6-151

Patient 4 (Igλ+ CBL) was classified in theIGL/IGL category, because both IGL rearrangements were identified, but the IGK rearrangement was not found.

Close Modal

or Create an Account

Close Modal
Close Modal